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Objective. While administration of intravenous tissue plasminogen activator (IV-tPA) is the standard of care in acute ischemic
stroke and has been shown to have statistically signiﬁcant beneﬁt, there can also be potentially life-threatening complications;
however, there is no standard informed consent approach. The purpose of this study was to present a parental, technical, and
general model of informed consent for IV-TPA and to determine which approach was preferred. Methods. Survey respondents
were asked to hypothetically decide whether or not to provide consent for their family member to receive IV-tPA. Respondents
were presented with 3 informed consent models: one emphasizing parental qualities, one emphasizing statistical data, and one
representing a general consent statement. After being presented each model, the respondents had to select their preferred consent
model, as well as rate their level of agreeability toward their family member receiving the medication following each approach.
Results. The results of 184 surveys showed respondents were equally as likely to give consent for their family member to receive IVTPA following all three approaches; however, respondents were signiﬁcantly more likely to prefer the parental approach
compared to a technical or general approach. Conclusion. Our results indicate that while paternalism is generally discouraged in
the medical community, some degree of parental language may be preferred by patients in tough decision-making situations
toward consent to receive medical interventions.

1. Introduction
The term “Informed consent” is credited to attorney Paul G.
Gebhard, as part of a medical malpractice case in the United
Stated in 1957 [1]. However, the idea that physicians should
fully inform patients about medical details in order to aid in
their care dates back as far as 1849 to the American physician
Worthington Hooker [1]. This concept was neither popular
nor adopted into practice at that time [1]. In fact, in 1847, the
American Medical Association published the American
Medical Association Code of Medical Ethics which supported
the idea that patients had a right to the truth except when
physicians felt like they could improve care by withholding
information [1]. This paternalistic, now also termed parental

approach, was the standard practice model for medical
decision-making until the concept of shared decisionmaking was introduced and ﬁrst mentioned in the literature
in 1982 [2]. Since then, there have been numerous publications supporting the importance of shared decisionmaking in both patient satisfaction and outcomes, and the
shared decision-making model is now the standard of care
for all decision-making in medicine [3]. It is important to
diﬀerentiate shared decision-making from the formal informed consent used in research settings since the Nuremburg Code was established in 1947 [4]. There is a lot of
overlap between informed consent and shared decisionmaking, but the diﬀerence lies in the extent the patient is
actively involved in each process. Informed consent is the
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legal standard obligation of a healthcare provider to educate
patients of the potential beneﬁts and harms of any procedure
or treatment, while shared decision-making highlights the
importance of a thorough discussion of all options available
to a patient allowing the patient to direct the treatment
decision that is most consistent with his or her values.
Despite widespread acceptance of shared decision-making
and its adoption into practice, very limited data are available
on applying these models in an emergency setting.
While administration of intravenous tissue plasminogen
activator (IV-tPA) is the standard of care in acute ischemic
stroke and has been shown to have statistically signiﬁcant
beneﬁt with minimal risk in eligible patients, there can also
be potentially life-threatening complications [5]. As such,
many clinicians seek verbal informed consent prior to its
administration; however, there is no standard IV-tPA
consenting protocol. Often, clinicians adopt a statistical
approach for IV-TPA informed consent by presenting risk/
beneﬁt statistics reported in the National Institute of
Neurological Disorders and Stroke tPA Stroke Study;
however, there are currently no data available to help understand if this approach aids in patient knowledge or
conﬁdence in decision-making, from the patients’ perspective, in the setting of consenting for IV-tPA.
The purpose of this study was to present three distinct
informative paragraphs/approaches that may be used in IVtPA informed consent, and each paragraph used language
and content of either a parental, technical, or general model
of informed consent. After presented with all three models,
respondents were asked to indicate which model was easiest
to understand or would have the largest impact on IV-tPA
decision-making for themselves or a family member. Our
hypothesis is that the majority of respondents would prefer a
parental approach, compared to a technical or general
approach.

2. Methods
This study was approved by the West Virginia University
Institutional Review Board. A voluntary survey was distributed to West Virginia University Hospital cafeteria adult
visitors, comprising hospital employees, healthy patients,
and visitors, in a hospital setting. The survey prompted
respondents to imagine that their family member was experiencing an acute ischemic stroke, and they must decide
whether or not to consent for their family member to receive
IV-tPA. Respondents were presented with three distinct
informative paragraphs/approaches that may be used in IVtPA informed consent, and each paragraph used language
and content of either a parental, technical, and general
approach to informed consent. The survey text for each
approach is provided in Table 1.
Respondents were asked to indicate a single, preferred
informed consent approach, as well as rate their level of
agreeability toward their family member receiving the
medication on a 5-increment scale (deﬁnitely agreeable,
probably agreeable, undecided, probably not agreeable,
deﬁnitely not agreeable) for each of the three informed
consent approaches, regardless of preference. Further,
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responses of “deﬁnitely agreeable” and “probably agreeable”
were considered overall agreeable, a response of “undecided”
considered uncertain, and responses of “deﬁnitely not
agreeable” and “probably not agreeable” considered overall
not agreeable.
2.1. Statistical Analysis. Descriptive statistics were used to
compare the respondent demographics—gender and education level. Survey responses were recorded as frequencies,
and a chi-square analysis was used to detect diﬀerences in
the proportions of approach preference and overall agreeableness toward each approach.

3. Results
A total of 184 respondents completed the survey. Of the
respondents, 62 were male (34%) and 122 were female
(66%). Respondents were also asked to indicate his or her
highest education level—7 did not complete high school
(4%), 57 completed high school only (31%), and 120 received
a bachelor’s degree or some other form of education beyond
high school (65%) (Table 2).
Respondents were equally as likely to give consent for
their family member to receive IV-TPA following all three
approaches, with 75 percent agreeable following a technical
approach, 84 percent agreeable following a parental approach, and 85 percent agreeable following a general approach (Table 3). Further, overall agreeability toward any
approach did not diﬀer on the basis of gender nor education
level.
Although there were no diﬀerences in overall agreeability between any of the three scenarios, respondents were
signiﬁcantly more likely to prefer the parental approach
compared to a statistical or general approach (p < 0.001), as
55 percent of respondents indicated parental approach as
their preferred scenario (Table 3). Not only did a signiﬁcant
majority of respondents indicate that a parental approach
was their preferred approach, this approach was associated
with the lowest proportion of uncertainty. Only four percent
of respondents responded “undecided” regarding tPA administration following the parental approach, whereas 14
percent of respondents responded “undecided” following
both the statistical and general approaches (Table 3). Lastly,
neither scenario preference nor uncertainty diﬀered on the
basis of gender nor education level.

4. Discussion
The overall purpose of our study was to determine if a
parental approach to informed consent was the preferred
approach to informed consent, associated with the highest
degree of conﬁdence in IV-tPA administration decisionmaking, compared to a statistical or general approach. Although respondents were equally as likely to give consent for
their family member to receive IV-TPA following all three
approaches, respondents were signiﬁcantly more likely to
prefer the parental approach compared to a statistical or
general approach. Furthermore, a parental approach was
associated with the lowest proportion of uncertainty,
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Table 1: Survey text.
Scenario 1—General approach: “IV-TPA is an FDA-approved clot busting medication. Overall, your mother is more likely to beneﬁt from
this medication than be harmed from this medication. We would recommend you allowing us to give this medication to your mother”
Scenario 2—Technical approach: “IV-TPA is an FDA approved clot busting medication. Your mom has a 33% chance of improving from
this medication and a 6% chance of harming her with this medication. If you took 100 people and gave them this medication 33 of them
would get better, 60 of them wouldn’t get better, but they wouldn’t get worse, 6 of them would get worse but only minorly so, and 1 of them
would potentially have a life-threatening complication. Overall, we feel as though your mom is more likely to beneﬁt from this medication
than be harmed, and we would recommend you allowing us to give your mom this medication”
Scenario 3—Parental approach: “IV-TPA is an FDA approved clot busting medication. Our team has given this medication to thousands of
people over the years and our institution does an amazing job at keeping our patients safe when we give this medication, minimizing any
potential harm it could cause. This is a clot busting medication, so the major risk is bleeding, but we feel as though the potential beneﬁt
signiﬁcantly outweighs the minimal risk. I would recommend you letting us give this medication to your mother. I know this is an
extremely hard position to be in, but if I was in your shoes, I would want to give this medication to my loved one”

Table 2: Respondent demographics.
Demographic
Gender
Male
Female
Highest education
Did not complete HS
Completed HS
Some college
Bachelor’s degree

N (%)
62 (34)
122 (66)
7
57
70
50

(4)
(31)
(38)
(27)

Table 3: Scenario preference, agreeability, and uncertainty.
N (%)
Preference
Overall agreeability
Uncertainty

Scenario
1—general
29 (16%)
156 (85%)
25 (14%)

Scenario
2—technical
53 (29%)
138 (75%)
26 (14%)

Scenario
3—parental
102 (55%)
154 (84%)
7 (4%)

indicating the highest degree of conﬁdence in decisionmaking compared with the statistical or general approach.
Modern medical education tends to discourage physician paternalism while emphasizing the importance of patient autonomy and beneﬁcence; however, these two
principles are often at odds with each other. How can a
patient or their surrogate have total autonomy and possess
the requisite medical knowledge to make a decision that
truly promotes beneﬁcence above all else, especially in a
time-sensitive case such as acute ischemic stroke? Perhaps
some form of paternalism may be necessary to resolve this
paradox, and our results demonstrate the inﬂuence that
parental language can have in obtaining informed consent
for IV-tPA. It is crucial to develop a more standardized
approach or language utilized in consent for IV-tPA, with
consideration for the ethical and legal aspects of medicaldecision-making, to ensure that patients are provided the
statistical risk information, while using some parental language to allow patients or their caregivers to make the most
unbiased, informed decision.
The principle of shared decision-making tries to help
bridge this divide between beneﬁcence and autonomy by
challenging physicians to provide medical details and
treatment options. This encourages patients to make medical
treatment decision themselves, without personal bias from
the provider. Healthcare providers are coached to make

recommendations to patients based on medical knowledge
but are often discouraged to incorporate personal opinions
on which decision they feel a patient should make. Fundamentally, shared decision-making requires the patient to
be the center of the decision-making process and places
emphasis on the patient’s personal values and beliefs [6].
Once personal opinion from the provider is implemented in
the decision-making process, the model shifts from shared
decision-making toward a more parental approach, which is
heavily inﬂuenced by the provider’s own personal values and
beliefs which could diﬀer from the patient. In a comparison
study done by Murray et al. among diﬀerent models of
decision-making, 62% of respondents preferred shared
decision-making while only 9% preferred paternalism [7].
Like this study, most decision-making studies are done in a
primary care setting leaving limited understanding of this
process in an acute care setting. The results in our study are
in stark contrast with most historically conducted decisionmaking model studies and emphasize the need for further
research in this setting.
Although there are clearly preferences to style when it
comes to decision-making in diﬀerent scenarios, there still
remains variability between preferences regardless of the
setting.
Limitations to our study include the relatively small
number of participants, single-site demographics, and recruitment on a healthcare campus. All of these factors may
reduce the generalizability of our results, and future studies
are warranted to support the generalizability of these results
to other demographics. In addition, although we made every
attempt to create scenarios that were purely “parental,”
“statistical,” or “general,” the concurrent requirement to
create a consenting scenario consistent with the one used in
the real world meant that some elements of each are likely
present. Further, the parental scenario also included language that was not only the opinion of the provider but also
speciﬁc to our institution’s perceived successful with tPA
treatment.
Second, none of our scenarios explicitly addressed any
speciﬁc adverse events associated with tPA administration,
such as intracranial hemorrhage. Because no explicit discussion was part of the three scenarios in this study, it is
impossible to predict how any speciﬁc risk would impact
informed consent. For example, the question remains to be
asked, would patients be more agreeable to a parental
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approach with or without an explicit discussion of risk, or
more importantly, if this event would occur, would patients
feel that their consent was truly informed? Both of these
questions should be addressed in future studies.
Lastly, our hypothetical situation was, by design, a timedependent high stakes medical decision. It is more likely that
in such a situation, the patient or their surrogate will rely
more heavily on the provider’s advice, as compared to a
time-independent situation where patients may receive a
variety of treatment options and consider the information
over a longer period. Therefore, it is diﬃcult to generalize
our ﬁndings to medical decision-making as it is applied to
nonacute settings.

5. Conclusion
Despite the limitations of this study, our study represents a
step toward identifying an optimal approach in informed
consent, not just for IV-TPA administration, but that can be
utilized in numerous acute decision-making scenarios in a
clinical setting. Our results indicate that while paternalism is
generally discouraged, some degree of parental language
may improve patient agreeableness toward consent to receive medical interventions. While parental language seems
to increase agreeableness, it is important to ensure that
agreeability is on the basis of a thorough understanding of
risk/beneﬁt. It is our opinion that a combination of the
parental and statistical approach would be the most ethical,
informative approach; however, future studies are warranted
to determine the optimal approach.
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